Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Belgium

Research and Innovation Action · Running

3SI-CONTROL Integrated Anthelmintic-Based control of Taenia solium cysticercosis/taeniasis, Soil-transmitted Helminthiasis and Schistosomiasis: safety, effectiveness and implementation strategies

Coordinator
Universiteit Gent, Belgium
Runs
1 June 2025 to 31 May 2029
Status
Running
EU funding
€5.5m
Total cost
€5.5m
Partners
7 organisations in 5 countries
Type
Research and Innovation Action
Grant agreement
101190685

What the project is doing

In the project's own words, from its summary on CORDIS.

Control of soil transmitted helminths (STH) and Schistosomiasis (SCH) has been part of routine programmes for many years, yet, the efficacy and effectiveness of these programmes is challenged by low and failing drug efficacy and growing concerns of anthelmintic resistance, calling for a revision of the MDA-drug strategies. In this regard, the novel fixed-dose co-formulation (FDC) including albendazole and ivermectin has proven to be safe and to overcome most of the challenges in drug efficacy for STH.

For T. solium the situation is very different from STH and SCH as currently there are no countries routinely implementing control. 3SI-CONTROL will assess the safety and cost-effectiveness of the FDC co-administration with praziquantel in reducing the prevalence of T. solium, STH and SCH, in a randomised controlled trial embedded in solid implementation research. Results from 3SI-CONTROL will thereby provide a scientific evidence base on the safety and effectiveness of integration of T. solium control with STH and SCH, considering the One Health approach.

Beyond this, the substantial implementation research component will enable bridging the gap between the evidence-based practice (results on safety and effectiveness) and the actual implementation in the routine, real-world setting. These results, joined by a comprehensive dissemination and advocacy plan, will provide leverage to stimulate uptake of T. solium in the existing routine NTD control programmes, enabling the implementation of a safe and integrated control strategy with a higher effectiveness, tackling three top ranking NTDs.

By harnessing advanced concepts in One Health, implementation research, and pharmacovigilance, our project aims to deliver transformative impacts in NTD control, reducing the individual, social and economic burdens of resource poor rural populations.

Who is involved

OrganisationCityCountryRole
Universiteit GentGentBelgiumCoordinator
Fundacion Privada Instituto De Salud Global BarcelonaBarcelonaSpainParticipant
Hospital Clinic De BarcelonaBarcelonaSpainThird party
Fundacao ManhicaVila Da Manhica MaputoMZParticipant
Sokoine University of AgricultureMorogoroTZParticipant
University of Dar Es SalaamDar Es SalaamTZParticipant
University of ZambiaLusakaZMParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI